A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

NCT05613660 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
264
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

NovoBliss Research Pvt Ltd

Collaborators